The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor
Status:
Completed
Trial end date:
2019-03-07
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, pharmacokinetics, food effect, and
preliminary antitumor activities of BGB-283 in Chinese subjects with local advanced or
metastatic malignant solid tumor.